Egrifta was approved today for HIV Lipodystrophy related visceral fat

Egrifta was approved today for HIV Lipodystrophy related visceral fat

Now, let’s see if insurance companies and Medicare Part D will pay for it!

http://www.google.com/#sclient=psy&hl=en&site=&source=hp&q=egrifta+fda+approval&aq=1&aqi=g6g-m4&aql=&oq=egrifta&gs_rfai=Ciodne2TbTMJJh5rMBIOLlZwLAAAAqgQFT9BHaG0&fp=e101ff708d439543

Share this post